Dashboard
Curated content
Companies
Stats & Insights
Sectors
Investors
Transactions
Multiples
More organizations
Deep Dives
Knowledge base
Companies
ViaCyte
Team
Save
ViaCyte
Verified
First in Kind Cellular Treatment for Diabetes.
Launch date
1999
Employees
51-200 people
Market cap
-
Net debt
-
Enterprise valuation
$320m
(Public information from Jul 2022)
San Diego California (HQ)
http://viacyte.com
https://twitter.com/viacyte
https://www.facebook.com/viacyte
https://www.linkedin.com/company/viacyte-formerly-novocell-
B2B
manufacturing
health
biotechnology
pharmaceutical
hard tech
biotechnology
horizon europe
biotech and pharma
risk management
diabetes
personal health
Overview
Similar companies
Analytics
Notes
Job openings
Innovations (0)
Patents (126)
Authorizing premium user...